ISPOR 11th Annual International Meeting Award Recipients

At the ISPOR Eleventh Annual International Meeting, May 20-24, 2006, Marriott Philadelphia, Philadelphia, PA, USA, the ISPOR Awards Committee, chaired by C. Daniel Mullins, recognized recipients of ISPOR Research Excellence Awards, Contributed Paper Awards and Distinguished Service Awards.

The ISPOR Avedis Donabedian Outcomes Research Lifetime Achievement Award
The ISPOR Avedis Donabedian Outcomes Research Lifetime Achievement Award was established in honor of the late Avedis Donabedian MD. Dr. Donabedian was a renowned faculty member of the University of Michigan, School of Public Health who dedicated his life to improving the quality of health care and health care systems. After a long process that involved nominations, selection of a panel of finalists, the ISPOR Lifetime Achievement Awards Task Force, chaired by Joel Hay PhD, selected the recipient: George Torrance MBA, PhD Principal Consultant for i3 Innovus Professor Emeritus at McMaster University, Canada

2006 ISPOR Bernie J. O’Brien New Investigator Award
The ISPOR Bernie O’Brien New Investigator Award was established in 2004 to honor the long-standing commitment of Bernie J. O’Brien, PhD to training and mentoring new scientists in the fields of outcomes research and pharmacoeconomics. The ISPOR Bernie J. O’Brien New Investigator Award Task Force, chaired by Michael Drummond, PhD, selected the recipient: John F.P. Bridges PhD Health Economist, University of Heidelberg, Heidelberg, Germany

2006 ISPOR Research Excellence Awards
The recipients of the 2006 ISPOR Research Excellence Award (one for Methodology Excellence and one for Practical Application Excellence) are selected by the Awards Committee based upon publications that have appeared in respected peer-review journals and other communication venues (e.g. books, reports) during the preceding eighteen months from January 1 of the year awarded. The award selection is based upon the publication’s clear description of methods, along with the appropriate and creative applications (or proposal thereof in conceptual methodology work) of techniques to answer important questions in the field of pharmacoeconomics and outcomes research. Such publications will be expected to have much impact on the field, due to their acceptance and application by others.

And the 2006 recipient of the ISPOR Research Excellence Award for Methodology Excellence is… Maiwenn Al, PhD as the senior author of the research paper: “The Analysis of Incomplete Cost Data Due to Dropout.” Health Econ 2005;14:763-76; (Dr. Al will be presented her award at the 9th Annual European Congress in Denmark, Copenhagen)
And the 2006 recipient of the ISPOR Research Excellence Award for Practical Application Excellence is… Josephine Mauskopf PhD as senior author of the research paper: “HIV Antiretroviral Treatment: Early Versus Later.” J Acquir Immune Defic Syndr 2005;9:562-69.

A Special thanks to John Brooks PhD, Chair, ISPOR Research Excellence Award in Methodological Excellence and Ya-Chen Tina Shih MS, PhD, Chair, ISPOR Research Excellence Award in Practical Application Excellence and their Task Forces for selecting the Recipients!

ISPOR Best Contributed Podium and Poster Presentation Awards
The ISPOR Best Contributed Podium and Poster Presentation Awards were established in 1998 to recognize the scientific merit of podium and poster presentations at the ISPOR Annual International Meetings, Annual European Congresses, and Asia-Pacific Conferences. At this year’s International Meeting, the ISPOR Awards Committee evaluated approximately 68 podium presentations and over 450 poster presentations. Evaluations of scientific merit were based upon the following criteria: • Background provides appropriate perspective / context for the subject
• Objectives / research questions are clearly stated
• Research design / methods / modeling is appropriate and transparent (scores on this will determine winners in case of ties) • Data sources and/or sampling procedures are clear and appropriate
• Data analyses are appropriate
• Research objectives are met/addressed
• Implications of findings are discussed
• Factual information is kept separate from interpretations or implications • Abstract is presented in an unbiased manner
• Clarity of presentation

A SPECIAL THANKS GOES TO Benjamin M. Craig PhD, Chair, ISPOR Contributed Research Paper Awards Task Force -- Poster Presentations, AS WELL AS TO David Holdford, PhD, Chair, ISPOR Contributed Research Paper Awards Task Force -- Podium Presentations, FOR ALL THEIR EFFORTS IN SELECTING THE RECIPIENTS

And the recipients are...

BEST CONTRIBUTED RESEARCH AWARDS

Best Podium Presentations
CS4: FREQUENCY AND COST OF DISABILITY AMONG EMPLOYED INDIVIDUALS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Darkow T1, Kadlubek PJ1, Shah H2, Phillips AL2, Martön JP3, 1i3 Magnifi, An Ingenix Company, Eden Prairie, MN, USA, 2Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, CT, USA, 3Pfizer Pharmaceuticals Group, Pfizer Inc, New York, NY, USA

CE4: COST EFFECTIVENESS OF DRUG ELUTING STENTS (DES) COMPARED TO BARE METAL STENTS (BMS) USING “REAL WORLD" DATA
Blackhouse G, Bowen J, Tarride JE, Hopkins R, O’Reilly D, Goeree RA, McMaster University, Hamilton, ON, Canada

ID4: COMPLIANCE WITH ANTIBIOTIC TREATMENT GUIDELINES IN MEDICARE MANAGED CARE PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA (CAP) IN AMBULATORY SETTINGS
Wu JH1, Howard DH2, McGowan JE2, Turpin RS1, & Co., Inc, West Point, PA, USA, 2Rollins School of Public Health of Emory University, Atlanta, GA, USA

Best New Investigator Podium Presentations

FP4: NATIONAL ESTIMATES AND ASSOCIATED FACTORS OF ANTIPSYCHOTIC USE IN AMBULATORY CARE FROM 1996 TO 2003
Sankaranarayanan J1, Puumala S2, 1College of Pharmacy, University of Nebraska Medical Center, Omaha, NE, USA, 2College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA

HI3: THE EFFECTS OF STATIN (HMG-COA REDUCTASE INHIBITOR) COPAYMENTS AND STATIN ADHERENCE ON MEDICAL CARE OUTCOMES AND EXPENDITURES
Gibson TB1, Mark T2, Axelsen K3, Mackell J4, King H3, Baser O1, McGuigan K3, 1Thomson Medstat, Ann Arbor, MI, USA, 2Thomson, Washington, DC, USA, 3Pfizer Global Pharmaceuticals, New York, NY, USA, 4Pfizer, Inc, New York, NY, USA

CV1: INCREMENTAL EXPENDITURE OF TREATING HYPERTENSION IN THE UNITED STATES
Balu S1, Thomas J2, 1Abt Associates Inc, Lexington, MA, USA, 2Purdue University, West Lafayette, IN, USA

Best Student Podium Presentations

R1: A BAYESIAN ESTIMATION OF AN AVERAGE SF-6D PREFERENCE BASED SCORE FROM COMMONLY REPORTED SF-12 STATISTICS
Hanmer J, Fryback DG, University of Wisconsin - Madison, Madison, WI, USA

FP3: AN AUDIT OF 106 ECONOMIC ANALYSES CONTAINED IN AMCP DOSSIER SUBMISSIONS 2002-2005
Colmenero F1, Brauer C1, Sullivan SD2, Watkins JB3, Neumann PJ4, 1Harvard University, Boston, MA, USA, 2University of Washington, Seattle, WA, USA, 3Premera BC, Mountlake Terrace, WA, USA, 4Tufts University School of Medicine, Boston, MA, USA

ID1: GATEKEEPERS AND SENTINELS: IMPLICATIONS FOR DRUG UTILIZATION POLICY IN THE COMMUNITY SETTING
Kahan NR1, Waitman DA1, Kahan E2, Chinitz DP3, 1Leumit Health Fund, Tel-Aviv, Israel, 2Sackler Faculty of Medicine, Tel-Aviv University, Kfar Saba, Israel, 3The Hebrew University of Jerusalem School of Public Health, Jerusalem, Israel

Best Poster Presentations

PMC11: DEVELOPMENT OF A GLOBAL HEALTH ECONOMIC MODEL OF THE NATURAL HISTORY OF HPV INFECTION AND CERVICAL CANCER: CALIBRATION TO THE UNITED KINGDOM AND THE NETHERLANDS
Ferko N1, Kohli MA1, Martin A2, Drummond MF3, Gallivan S4, Sherlaw-Johnson C4, Phillips Z3, 1Innovus Research Inc, Burlington, ON, Canada, 2GlaxoSmithKline UK Limited, Uxbridge, Middlesex, UK, 3University of York, York, Heslington, UK, 4University College London, London, UK

PRO1: RESULTS OF ALTERNATIVE DEFINITIONS FOR STATIN REFILL COMPIANCE, PERSISTENCE AND GAPS IN A RETROSPECTIVE DATABASE ANALYSIS
Kochevar JJ, Williams TD, Kochevar Research Associates, Charlestown, MA, USA

PIN18: HOSPITAL LENGTH-OF-STAY AND COSTS ASSOCIATED WITH USE AND EARLIER INITIATION OF DROTRECOGIN ALFA (ACTIVATED) IN ADULT PATIENTS WITH THE HIGHEST PROPENSITY OF HAVING SEVERE SEPSIS
Ernst FR1, Viswanathan S2, Vedarajan G3, Reynolds J3, Kohli B3, 1Eli Lilly and Company, Indianapolis, IN, USA, 2ZS Associates, Boston, MA, USA, 3ZS Associates, Evanston, IL, USA

Best New Investigator Poster Presentations

PIN20-COMPARISON OF HEALTH OUTCOMES AMONG SEVERE COMMUNITY-ACQUIRED PNEUMONIA PATIENTS TREATED EMPIRICALLY WITH A BETA-LACTAM PLUS A MACROLIDE VERSUS A BETA-LACTAM PLUS A FLUOROQUINOLONE
Frei CR1, Restrepo MI2, Mortensen EM1, Burgess DS2, 1University of Texas at Austin and University of Texas Health Sci. Ctr. at San Antonio, San Antonio, TX, USA, 2University of Texas Health Sci. Ctr. at San Antonio, Vet. Evidence-Based Res. Dis. and Imp. Ctr, and South TX Health Care System, San Antonio, TX, USA

PGI1: HEPATITIS B IMMUNISATION FOR NEWBORNS OF HEPATITIS B SURFACE ANTIGEN-POSTITIVE MOTHERS: A COCHRANE HEPATO-BILIARY GROUP SYSTEMATIC REVIEW AND METAANALYSIS
Lee CF, Tri-Service General Hospital, Taipei, Taiwan

PMH8: COST-EFFECTIVENESS OF VENLAFAXINE: A CANADIAN PERSPECTIVE
Sadri H1, Han D1, Nourse A1, McIntyre RS2, 1Wyeth Pharmaceuticals, Markham, ON, Canada, 2Head, Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Toronto, ON, Canada

Best Student Poster Presentations

PEY7: VARIATIONS IN PHYSICIAN PRESCRIBING OF TOPICAL MEDICATIONS FOR GLAUCOMA IN US OUTPATIENT SETTINGS
Bhosle MJ, Balkrishnan R, The Ohio State University College of Pharmacy, Columbus, OH, USA

PMH24: INCREASING FORMULARY ACCESS TO INNOVATIVE DRUGS: DIFFERENCES FOR TREATING SCHIZOPHRENIA IN A MEDI-CAL POPULATION
Biagi V1, Crandall L2, McCombs J3, 1University of Miami, Fort Lauderdale, FL, USA, 2University of Miami, Miami, FL, USA, 3University of Southern California, Los Angeles, CA, USA

POB1: ASSOCIATION BETWEEN BMI AND HEALTH CARE EXPENDITURES USING THE 2002 MEDICAL EXPENDITURE PANEL SURVEY
Valderrama A, Lawrence L, University of Louisiana at Monroe, Monroe, LA, USA

ISPOR WOULD LIKE TO THANK ALL THE JUDGES WHO HAVE VOLUNTEERED THEIR TIME AND EFFORTS DURING THE MEETING TO SCORE PODIUM AND POSTER PRESENTATIONS

ISPOR SERVICE AWARDEES

PRESIDENT (2004-2005) & PAST PRESIDENT (2005-2006) Lieven Annemans MSc, PhD, Health Economist Ghent University, Senior Consultant Global Health Economic HEDM and IMS Health, Brussels, Belgium

DIRECTOR (2004-2006) Laurie Burke MPH, RPh, Director, Study Endpoints and Label Development, Office of New Drugs, CDER, FDA, Rockville, MD, USA

DIRECTOR (2004-2006) Jens Grueger PhD, Head of Pricing and Health Economics Department, Novartis Pharmaceuticals AG, Basel, Switzerland

DIRECTOR (2004-2006) Isao Kamae MD, DrPH, Professor of Biostatistics and Health Decision Sciences, Graduate School of Medicine, Kobe University, Kobe, Japan

ELEVENTH ANNUAL INTERNATIONAL MEETING PROGRAM CHAIR Joanna Siegel, ScD, RN, Director, Research Initiative in Clinical Economics, Agency for Healthcare Research & Quality, Rockville, MD, USA

ISPOR EDUCATION COMMITTEE CHAIR Karen Rascati RPh, PhD, Professor, College of Pharmacy, University of Texas, Austin, TX, USA

ISPOR AWARDS COMMITTEE CHAIR C. Daniel Mullins PhD, Professor and Chair, Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD, USA

BUDGET IMPACT ANALYSIS TASK FORCE CHAIRS Jo Mauskopf PhD, Division Director, RTI Health Solutions, RTI International, Research Triangle Park, NC, USA; Sean Sullivan PhD, RPh, MS, Professor and Director, Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA, USA

USE OF ECONOMIC INFORMATION IN HEALTH CARE DECISIONS TASK FORCE CHAIR Michael F. Drummond PhD, Professor of Health Economics, University of York, York, UK STUDENT NETWORK CHAIR (2005-2006) Josh Epstein MA, University of Southern California, CA, USA

ISPOR STUDENT CHAPTER PRESIDENTS

Florida A&M University-Chapter President Jennifer Sexton, Tallahassee, FL, USA

Harvard University-Chapter President Si-Tien Mary Wang, Cambridge, MA, USA

Ohio State University-Chapter President Jay Visaria, Columbus, OH, USA

Purdue University-Chapter President Menaka Bhor MS, West Lafayette, IN, USA

Rutgers University-Chapter President Lien Vo PharmD, New Brunswick, NJ, USA

University of Arizona-Chapter President Kirsten Yaffe, Tucson, AZ, USA

University of Florida-Chapter President Annesha White PharmD, MS, Gainseville, FL, USA

University of Georgia-Chapter President Olatoye Oyelowo, Athens, GA, USA

University of Houston-Chapter President Kavita Sail, Houston, TX, USA

University of Illinois at Chicago-Chapter President Nasreen Khan MS, Chicago, IL, USA

University of Louisiana at Monroe-Chapter President Adriana Valderrama MBA, Monroe, LA, USA

University of Maryland-Chapter President Andrew Levine, Baltimore, USA

University of Michigan--Chapter President Usha Mallya MS, Ann Arbor, MI, USA

University of Minnesota-Chapter President Joshua Devine PharmD, Minneapolis, MN, USA

University of New Mexico-Chapter President Heather Campbell PharmD, Albuquerque, NM, USA

University of Rhode Island-Chapter President Mark Regine, Kingston, RI, USA

University of Southern California-Chapter President Pamela Vo PharmD, Los Angeles, CA, USA

University of Tennessee-Chapter President Joyce Addo-Atuah MS, Memphis, TN, USA

University of Texas at Austin-Chapter President Roxanne Cantu PharmD, Austin, TX USA

University of the Sciences in Philadelphia-Chapter President Stephen Chang PharmD, Philadelphia, PA, USA

University of Utah-Chapter President Kenneth Brown PharmD, Park City, UT, USA

Virginia Commonwealth University-Chapter President Seina Lee PharmD, Richmond, VA, USA

West Virginia University-Chapter President Vivek Pawar MS, Morgantown, WV, USA

West Virginia University-Membership Outreach Chair Sanjoy Roy, Morgantown, WV, USA

  Issues Index | 2006 Issues Index